/ Not yet recruitingPhase 3 A Multicentre, Randomised, Placebo-controlled, Double-blinded Study of the Efficacy, Safety, and Pharmacokinetics of Lubiprostone in Paediatric Subjects Aged = 6 Years to < 18 Years with Functional Constipation
100 Clinical Results associated with Sucampo Pharma Europe Ltd.
0 Patents (Medical) associated with Sucampo Pharma Europe Ltd.
01 Nov 2014·Value in HealthQ2 · MEDICINE
Lubiprostone In Chronic Idiopathic Constipation: A Cost-Effectiveness Analysis
Q2 · MEDICINE
Article
Author: Hatswell, A J ; Sophia, H ; Lichtlen, P ; Pennington, B ; Marriott, E
100 Deals associated with Sucampo Pharma Europe Ltd.
100 Translational Medicine associated with Sucampo Pharma Europe Ltd.